Terms: = Endocrine gland cancer AND NF1, NFNS, 4763, ENSG00000196712, P21359
337 results:
1. Genetic disorders and insulinoma/glucagonoma.
Marini F; Giusti F; Brandi ML
Endocr Relat Cancer; 2024 May; 31(5):. PubMed ID: 38552306
[TBL] [Abstract] [Full Text] [Related]
2. Undifferentiated Carcinoma with Osteoclast-like Giant Cells of the Pancreas: Molecular Genetic Analysis of 13 Cases.
Hrudka J; Kalinová M; Ciprová V; Moravcová J; Dvořák R; Matěj R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542259
[TBL] [Abstract] [Full Text] [Related]
3. Somatic Genomic and Transcriptomic Characterization of Primary Ovarian Serous Borderline Tumors and Low-Grade Serous Carcinomas.
Stružinská I; Hájková N; Hojný J; Krkavcová E; Michálková R; Bui QH; Matěj R; Laco J; Drozenová J; Fabian P; Škapa P; Špůrková Z; Cibula D; Frühauf F; Jirásek T; Zima T; Méhes G; Kendall Bártů M; Němejcová K; Dundr P
J Mol Diagn; 2024 Apr; 26(4):257-266. PubMed ID: 38280423
[TBL] [Abstract] [Full Text] [Related]
4. Genomic profiling of primary and metastatic thyroid cancers.
Máximo V; Melo M; Zhu Y; Gazzo A; Sobrinho Simões M; Da Cruz Paula A; Soares P
Endocr Relat Cancer; 2024 Feb; 31(2):. PubMed ID: 38015791
[TBL] [Abstract] [Full Text] [Related]
5. Survey of nf1 inactivation by surrogate immunohistochemistry in ovarian carcinomas.
Köbel M; Yang RZ; Kang EY; Al-Shamma Z; Cook LS; Kinloch M; Carey MS; Hopkins L; Nelson GS; McManus KJ; Vizeacoumar FS; Vizeacoumar FJ; Freywald A; Fu Y; Reuss DE; Lee CH
Gynecol Oncol; 2023 Nov; 178():80-88. PubMed ID: 37820398
[TBL] [Abstract] [Full Text] [Related]
6. Targeting RAS-ERK pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancers.
Nguyen NT; Raetz A; Montoya D; Schilling V; Tong C; Brooks RA; Leiserowitz G; Chien J
Gynecol Oncol; 2023 Nov; 178():69-79. PubMed ID: 37806229
[TBL] [Abstract] [Full Text] [Related]
7. Pheochromocytoma and paraganglioma in children and adolescents.
Stachowicz-Stencel T; Pasikowska N; Synakiewicz A
Acta Biochim Pol; 2023 Sep; 70(3):487-493. PubMed ID: 37717273
[TBL] [Abstract] [Full Text] [Related]
8. endocrine morbidity in neurofibromatosis 1: a nationwide, register-based cohort study.
Kenborg L; Ebbehoj A; Ejerskov C; Handrup MM; Østergaard JR; Hove H; Doser K; Krøyer A; Mulvihill JJ; Winther JF; Stochholm K
Eur J Endocrinol; 2023 Aug; 189(2):190-198. PubMed ID: 37542520
[TBL] [Abstract] [Full Text] [Related]
9. A putative role for ALDH inhibitors and chemoprevention of BRCA-mutation-driven tumors.
McGonigal S; Wu R; Grimley E; Turk EG; Zhai Y; Cho KR; Buckanovich RJ
Gynecol Oncol; 2023 Sep; 176():139-146. PubMed ID: 37535994
[TBL] [Abstract] [Full Text] [Related]
10. Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian cancer.
Desai NV; Barrows ED; Nielsen SM; Hatchell KE; Anderson MJ; Haverfield EV; Herrera B; Esplin ED; Lucassen A; Tung NM; Isaacs C
JCO Precis Oncol; 2023 Aug; 7():e2200695. PubMed ID: 37535880
[TBL] [Abstract] [Full Text] [Related]
11. Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer.
Adamson AW; Ding YC; Steele L; Leong LA; Morgan R; Wakabayashi MT; Han ES; Dellinger TH; Lin PS; Hakim AA; Wilczynski S; Warden CD; Tao S; Bedell V; Cristea MC; Neuhausen SL
J Ovarian Res; 2023 Jul; 16(1):141. PubMed ID: 37460928
[TBL] [Abstract] [Full Text] [Related]
12. [Pheochromocytoma associated with primary hyperparathyroidism and type 1 neurofibromatosis].
Ryabchenko EV; Dremlyuga NV; Mezhinskaya EM; Polyansky EA
Khirurgiia (Mosk); 2023; (7):120-127. PubMed ID: 37379415
[TBL] [Abstract] [Full Text] [Related]
13. A comprehensive study on surveillance outcomes of a male population followed at a hereditary breast cancer high-risk consultation at a Portuguese tertiary hospital.
Oliveira MJ; Costa S; Magalhães A; Garrido L; Peleteiro B; Fougo JL; Castedo S
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11145-11156. PubMed ID: 37347260
[TBL] [Abstract] [Full Text] [Related]
14. Domain landscapes of somatic nf1 mutations in pheochromocytoma and paraganglioma.
Tabebi M; Frikha F; Volpe M; Gimm O; Söderkvist P
Gene; 2023 Jul; 872():147432. PubMed ID: 37062455
[TBL] [Abstract] [Full Text] [Related]
15. Molecular Genetics of Diffuse Sclerosing Papillary Thyroid cancer.
Alswailem M; Alghamdi B; Alotaibi A; Aljomiah A; Al-Hindi H; Murugan AK; Abouelhoda M; Shi Y; Alzahrani AS
J Clin Endocrinol Metab; 2023 Aug; 108(9):e704-e711. PubMed ID: 36995892
[TBL] [Abstract] [Full Text] [Related]
16. Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer.
Foster KI; Shaw KRM; Jin J; Westin SN; Yap TA; Glassman DM; Jazaeri AA; Rauh-Hain JA; Lee S; Fellman BM; Ju Z; Liu Y; Fleming ND; Sood AK
Cancer; 2023 Jun; 129(11):1672-1680. PubMed ID: 36930815
[TBL] [Abstract] [Full Text] [Related]
17. Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
Bychkovsky BL; Lo MT; Yussuf A; Horton C; Hemyari P; LaDuca H; Garber JE; Scheib R; Rana HQ
Breast Cancer Res Treat; 2023 Jul; 200(1):63-72. PubMed ID: 36856935
[TBL] [Abstract] [Full Text] [Related]
18. Co-occurrence of mutations in
Mellid S; Gil E; Letón R; Caleiras E; Honrado E; Richter S; Palacios N; Lahera M; Galofré JC; López-Fernández A; Calatayud M; Herrera-Martínez AD; Galvez MA; Matias-Guiu X; Balbín M; Korpershoek E; Lim ES; Maletta F; Lider S; Fliedner SMJ; Bechmann N; Eisenhofer G; Canu L; Rapizzi E; Bancos I; Robledo M; Cascón A
Front Endocrinol (Lausanne); 2022; 13():1070074. PubMed ID: 36760809
[TBL] [Abstract] [Full Text] [Related]
19. Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues.
Gan M; Tai Z; Yu Y; Zhang C; Xu J
PeerJ; 2023; 11():e14653. PubMed ID: 36721777
[TBL] [Abstract] [Full Text] [Related]
20. MULTIPLE NEUROendocrine NEOPLASIA IN A PATIENT WITH TYPE I NEUROFIBROMATOSIS (nf1): REPORT OF A NEW MUTATION (nf1, EXONS 2-30 DELETION) AND LITERATURE REVIEW.
Kanno DT; Mattos RLM; Campos FG; Siqueira RM; Carvalho RB; Real Martinez CA
Arq Bras Cir Dig; 2023; 35():e1702. PubMed ID: 36629684
[TBL] [Abstract] [Full Text] [Related]
[Next]
